Accordingly, PREX2 is widely considered an oncogene due to its promotion of tumor proliferation, migration, and invasion in numerous neoplasms (i.e., glioma, melanoma, and breast, ovarian, prostatic, and pancreatic cancers) when mutated or overexpressed [68,69,70,71]. Here, PREX2 is linked to glioma.